Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-110-1 | CAS number: 115-83-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Description of key information
No data on reproductive toxicity / effects on fertility for the target substance are needed because reliable information on pre-natal developmental toxicity studies for adequate source substances are available. Moreover, based on the results of available sub-acute repeated dose toxicity studies investigating parameters of reproductive toxicity for adequate source substances and on toxicokinetic considerations, no adverse effects on reproductive organs and tissues are expected for the target substance.
Effect on fertility: via oral route
- Endpoint conclusion:
- no study available
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no study available
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Additional information
No data on reproductive toxicity / effects on fertility for the target substance are needed because reliable information on pre-natal developmental toxicity studies for adequate source substances are available. Moreover, data taken from repeated dose toxicity studies are available including a sub-chronic study with Pentanoic acid, mixed esters with PE, isopentanoic acid and isononanoic acid (CAS 146289-36-3) and subacute studies for the analogue substances Fatty acids, C5-10, esters with pentaerythritol (CAS 68424-31-7), and Fatty acids, C8-10 mixed esters with dipenaterythritol, isooctanoic acid, pentaerythritol and tripentaerythritol (CAS 189200-42-8).
In a 90-day oral repeated dose toxicity study with Pentanoic acid, mixed esters with PE, isopentanoic acid and isononanoic acid (CAS 146289-36-3) up to a dose of 1000 mg/kg bw/day no abnormalities were reported for histopathological examination of the reproductive organs including epididymides, ovaries, prostate, seminal vesicle, mammary glands, testes, and uterus, and no effects on organ weights of epididymides, testes, ovaries, and testes were seen.
In a 28-day oral repeated dose toxicity study with Fatty acids, C5-10, esters with pentaerythritol (CAS 68424-31-7) up to a dose of 1450 (males) and 1613 (females) mg/kg bw/day examination of gross pathology and histopathology revealed no adverse effects on reproductive organs (cervix, epididymis, mammary gland, ovaries, prostate gland, seminal vesicles, testes, and uterus).
In a 28-day oral repeated dose toxicity study with Fatty acids, C8 -10 mixed esters with dipenaterythritol, isooctanoic acid, pentaerythritol and tripentaerythritol (CAS 189200 -42 -8) up to a dose of 1000 mg/kg
no treatment-related adverse effects on testes and ovaries were observed.
Conclusion on reproductive toxicity / effects on fertility
Based on the results of available oral repeated dose toxicity studies investigating parameters of reproductive toxicity for adequate source substances and on toxicokinetic considerations, no adverse effects on reproductive organs and tissues are expected for the target substance pentaerythritol tetrastearate (CAS 115-83-3).
Effects on developmental toxicity
Description of key information
Oral: OECD 414, GLP, rat, NOAEL developmental ≥ 1000 mg/kg bw/day
Link to relevant study records
- Endpoint:
- developmental toxicity
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Remarks:
- Summary of available data used for the endpoint assessment of the target substance
- Adequacy of study:
- key study
- Justification for type of information:
- Please refer to the Analogue Approach Justification provided in Section 13.
- Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across source
- Key result
- Dose descriptor:
- NOAEL
- Remarks:
- systemic
- Effect level:
- >= 1 000 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Basis for effect level:
- other: NOAEL is corresponding to the highest dose tested
- Remarks on result:
- other: Source: CAS 189200-42-8
- Key result
- Abnormalities:
- no effects observed
- Key result
- Dose descriptor:
- NOAEL
- Remarks:
- developmental
- Effect level:
- >= 1 000 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: NOAEL is corresponding to the highest dose tested
- Remarks on result:
- other: Source: CAS 189200-42-8, Exxon, 1995h
- Key result
- Abnormalities:
- no effects observed
- Key result
- Developmental effects observed:
- no
- Conclusions:
- The read-across approach is justified in the analogue justification. The target and source substances are considered unlikely to differ in their developmental toxicity potential. In a developmental toxicity study with the source substance Fatty acids, C8-10 mixed esters with dipentaerythritol, isooctanoic acid, pentaerythritol and tripentaerythritol (CAS 189200-42-8) administered via oral gavage the NOAEL for maternal toxicity, embryo- / fetotoxicity and teratogenicity were found to be ≥1000 mg/kg bw/day. No hazard for developmental toxicity is expected for the target substance Pentaerythritol tetrastearate (CAS 115-83-3).
Reference
Data from the source substance Fatty acids, C8 -10 mixed esters with dipentaerythritol, isooctanoic acid, pentaerythritol and tripentaerythritol (CAS 189200-42-8) was selected as key result for reasons of structural similarity and data reliability.
Data from the source substances Fatty acids, C5-9 tetraesters with pentaerythritol (CAS 67762-53-2) was used as supportive data. In a developmental toxicity study Fatty acids, C5 -9 tetraesters with pentaerythritol (CAS 67762 -53 -2) was administered daily during gestation days 0 -19 via the dermal route of administration at 0, 800, and 2000 mg/kg bw/day. Soft tissue examination in the study revealed an increased number of foetuses with levocardia, but the internal anatomy of the heart was normal and no accompanying heart or other malformations in the thoracic cavity were detected. It is important to note that the term levocardia as used in the study report describes the placement of the heart in the extreme left hemithorax without any reversal of organs or any other malformations. It is therefore concluded that the effect observed has no toxicological relevance for humans. The NOAEL for embryo- / fetotoxicity and teratogenicity in rats was however found to be < 800 mg/kg bw/day and the LOAEL = 800 mg/kg bw/day.
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 1 000 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rat
- Quality of whole database:
- The available information comprises an adequate and reliable (Klimisch score 2) study from a source substance with similar structure and intrinsic properties. Read-across is justified based on common precursors and hydrolysis products and consistent trends in environmental fate, ecotoxicological and toxicological profile. The selected study is thus sufficient to fulfil the standard information requirements set out in Annexes VIII - X, 8.7, in accordance with Annex XI, 1.5, of Regulation (EC) 1907/2006.
Effect on developmental toxicity: via inhalation route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via dermal route
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LOAEL
- 800 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rat
- Quality of whole database:
- The available information comprises an adequate and reliable (Klimisch score 2) study from a source substance with similar structure and intrinsic properties. Read-across is justified based on common precursors and hydrolysis products and consistent trends in environmental fate, ecotoxicological and toxicological profile. The selected study is thus sufficient to fulfil the standard information requirements set out in Annexes VIII - X, 8.7, in accordance with Annex XI, 1.5, of Regulation (EC) 1907/2006.
Additional information
No data on the potential for reproduction toxicity of the target substance pentaerythritol tetrastearate (CAS 115-83-3) are available. The assessment was therefore based on studies conducted with analogue substances as part of a read-across approach, which is in accordance with Regulation (EC) 1907/2006, Annex XI, 1.5. For each specific endpoint source substances are chosen for read-across, with due regard to the requirements of adequacy and reliability of the available data. Structural similarities and similarities in properties and/or activities of the source and target substance are the basis of read-across. A detailed justification for the analogue read-across approach is provided in the technical dossier (see IUCLID Section 13).
Developmental toxicity
Studies from two source substances investigating pre-natal developmental toxicity were available. While administration of the test substance in one study was by oral gavage, the dermal route of exposure was utilised in the second study.
The developmental toxicity of Fatty acids C8-10, mixed esters with dipentaerythritol, isooctanoic acid, pentaerythritol and tripentaerythritol (CAS 189200-42-8) was investigated according to OECD guideline 414 (prenatal developmental toxicity study) and under GLP conditions (key study, 1995). 50 male Sprague-Dawley rats were mated with females to achieve groups of 25 pregnant Sprague-Dawley rats which then received daily oral gavage doses of the test substance at concentrations of 100, 500 and 1000 mg/kg bw/day during gestational days 6 to 15. Control animals received the vehicle polyethylene glycol (PEG 400) only. On day 21 of gestation the animals were euthanized and examined for maternal and fetal parameters. There were no adverse effects found for all parameters examined in maternal animals. Based on the number of implantations, number of total litter losses by resorption, mortality, clinical signs, body weight, gross pathology and organ weights of maternal animals the NOAEL for maternal systemic toxicity was found to be 1000 mg/kg bw/day. Examination of fetus litter size and weights, offspring viability (number alive and number dead), sex ratio, grossly visible abnormalities, external, head, soft tissue and skeletal abnormalities showed only incidental malformations in two high dose females. The NOAEL for embryo-/fetotoxicity and teratogenicity in rats of the test substance was therefore found to be 1000 mg/kg bw/day.
In another developmental toxicity study Fatty acids, C5-9, tetraesters with pentaerythritol (CAS 67762-53-2) was investigated comparable to OECD guideline 414 (prenatal developmental toxicity study) (supporting study, 1988). Groups of 15 presumed pregnant female Sprague-Dawley rats received daily dermal doses of the test substance at concentrations of 800 and 2000 mg/kg bw/day during gestational days 0 to 19. Control animals remained untreated. On day 20 of gestation the animals were euthanized and examined for maternal and fetal parameters. There were no adverse effects found for all parameters examined in maternal animals. Based on the number of implantations, number of total litter losses by resorption, mortality, clinical signs, body weight, gross pathology and organ weights of maternal animals the NOAEL for maternal systemic toxicity was found to be 2000 mg/kg bw/day. Examination of fetus litter size and weights, offspring viability (number alive and number dead), sex ratio, grossly visible abnormalities, external, head, soft tissue and skeletal abnormalities revealed no differences to controls and thus no indication for teratogenic effects. Soft tissue examination revealed an increased number of fetuses with “levocardia” but the internal anatomy of the heart was normal and no accompanying heart or other malformations in the thoracic cavity were detected. It is important to note that the term levocardia as used in the study report describes the placement of the heart in the extreme left hemithorax without any reversal of organs or any other malformations or adverse effects. It is therefore concluded that the effect observed has no toxicological relevance for humans. However, since levocardia was observed in both treated groups, the LOAEL for embryo- / fetotoxicity and teratogenicity in rats for Fatty acids, C5 -9, tetraesters with pentaerythritol under the experimental conditions of the study was determined to be 800 mg/kg bw/day.
Conclusion on developmental toxicity
Although in one of the studies referred to “levocardia” in rats after dermal exposure was detected, it could be demonstrated that this effect has no toxicological relevance for humans as the effect described the positioning of the heart in the extreme left hemithorax was without any further adverse implications and malformations. Therefore, based on the available data and following the analogue approach, no hazard for developmental toxicity was identified for the target substance Pentaerythritol tetrastearate (CAS 115 -83 -3).
Mode of Action Analysis / Human Relevance Framework
Not applicable.
Justification for classification or non-classification
According to Article 13 of Regulation (EC) 1907/2006 information on intrinsic properties of substances may be generated by means other than tests, e.g. using information from structurally related substances (grouping or read-across), provided that conditions set out in Annex XI are met. Annex XI states that “substances whose physicochemical, toxicological and ecotoxicological properties are likely to be similar or follow a regular pattern as a result of structural similarity may be considered as a group, or ‘category’ of substances. This avoids the need to test every substance for every endpoint". Since the read-across concept is applied to the target substance pentaerythritol tetrastearate (CAS 115 -83 -3), data gaps can be filled by interpolation from representative structural analogue source substances to avoid unnecessary animal testing.
The read-across concept is also used to derive the classification of the target substance taking the properties of the source substances into account. Based on the read-across concept, all available data on reproductive and developmental toxicity do not indicate a hazard for reproduction toxicity.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.